Polarean Imaging Plc (LON:POLX) has appointed the former chief financial officer (CFO) of an oncology therapeutics firm as its new finance boss.
The medical imaging firm said Charles (Chuck) Osborne, Jr, who joins the company from Innocrin Pharmaceuticals Inc, would begin the role with immediate effect and will replace outgoing CFO Bill Patrick, who would take up the post of financial controller at Polarean Inc, the group’s subsidiary.
READ: Polarean Imaging signs deal with University of British Colombia
Prior to his role at Innocrin, Osborne was CFO of anti-infective therapy group Scynexis Inc (NASDAQ:SCYX).
Richard Hullihen, Polarean’s chief executive, said Osborne’s “previous capital markets experience coupled with his knowledge of financial operations within the pharmaceutical industry will ensure strong leadership of the Company's financial function”.